Concepedia

Michael Heim

MH

Statistics

Publications

3

Citations

64

H-Index

3

Active since

2022

Affiliations

Medical College of Wisconsin(Current)

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

McMaster University

Tel Aviv Sourasky Medical Center

Michael Heim is an author at Medical College of Wisconsin specializing in oncology, cell therapy, and hematology.

Publications per year

2022–2025

3

Publications

3

Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar et al. · Blood · 2023 · 29 citations

, , +15

Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Daniel J. Landsburg, Matthew J. Frigault, Michael Heim et al. · Blood · 2022 · 22 citations

, , +16

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Daniel J. Landsburg, Matthew J. Frigault, Michael Heim et al. · Journal for ImmunoTherapy of Cancer · 2025 · 13 citations · Full text

, , +12

1–3 of 3